Pacific Bio (PACB) Misses Q2 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Trex raises 2026 guidance, names SBP as sole national distributor
• JPMorgan Starts Shinsegae Inc (004170:KS) at Overweight